Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure

American Heart Journal

Volumn 153, Issue 4 SUPPL., 2007, Pages 81-84

  Marie Valente, Anne ^a   Rhodes, John F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATHETER ABLATION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HUMAN; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS;

EID: 33947541282     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.011     Document Type: Article

References (51)

1. Perloff J.K. Longevity in congenital heart disease: a tribute to pediatric cardiology. J Pediatr 122 (1993) S49-S58
2. Samanek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol 13 (1992) 152-158
3. Campbell M. Natural history of atrial septal defects. Br Heart J 32 (1970) 820-826
4. Murphy J.G., Gersh B.J., McGoon M.D., et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 323 (1990) 1645-1650
5. Gatzoulis M.A., Freeman M.A., Siu S.C., et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 340 (1999) 839-846
6. Varma C., Benson L.N., Silversides C., et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc Interv 61 (2004) 131-139
7. Van Praagh S., Carrera M.E., Sanders S.P., et al. Sinus venosus defects: unroofing of the right pulmonary veins-anatomic and echocardiographic findings and surgical treatment. Am Heart J 128 (1994) 365-379
8. Silverman N.H., Zuberbuhler J.R., and Anderson R.H. Atrioventricular septal defects: cross-sectional echocardiographic and morphologic comparisons. Int J Cardiol 13 (1986) 309-331
9. Cragun D.T., Lax D., and Butman S.M. Look before you close: atrial septal defect with undiagnosed partial anomalous pulmonary venous return. Catheter Cardiovasc Interv 66 (2005) 432-435
10. de Lezo J.S., Medina A., Romero M., et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J 144 (2002) 877-880
11. Kobayashi J., Yamamoto F., Nakano K., et al. Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation 98 Suppl 19 (1998) II399-II402
12. Giardini A., Donti A., Formigari R., et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol 43 (2004) 1886-1891
13. Masura J., Gavora P., and Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer Septal Occluders. J Am Coll Cardiol 45 (2005) 505-507
14. Wang J.K., Tsai S.K., Wu M.H., et al. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am Heart J 148 (2004) 511-517
15. Du Z.D., Hijazi Z.M., Kleinman C.S., et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39 (2002) 1836-1844
16. Suda K., Raboisson M.J., Piette E., et al. Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol 43 (2004) 1677-1682
17. Willcoxson F.E., Thomson J.D., and Gibbs J.L. Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparin. Heart 90 (2004) e30
18. Mashman W.E., King S.B., Jacobs W.C., et al. Two cases of late embolization of Amplatzer Septal Occluder devices to the pulmonary artery following closure of secundum atrial septal defects. Catheter Cardiovasc Interv 65 (2005) 588-592
19. Amin Z., Hijazi Z.M., Bass J.L., et al. Erosion of Amplatzer Septal Occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63 (2004) 496-502
20. Grayburn P.A., Schwartz B., Anwar A., et al. Migration of an Amplatzer Septal Occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol 96 (2005) 1607-1609
21. Koenig P., and Cao Q.L. Echocardiographic guidance of transcatheter closure of atrial septal defects: is intracardiac echocardiography better than transesophageal echocardiography?. Pediatr Cardiol 26 (2005) 135-139
22. Kort H.W., Balzer D.T., and Johnson M.C. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol 38 (2001) 1528-1532
23. Du Z.D., Cao Q.L., Koenig P., et al. Speed of normalization of right ventricular volume overload after transcatheter closure of atrial septal defect in children and adults. Am J Cardiol 88 (2001) 1450-1453 A9
24. Harrison J., Valente A.M., Crowley A.L., et al. Clinical use of cardiac magnetic resonance imaging. Adv Stud Med 5 (2005) 351-359
25. Ries M.W., Kampmann C., Rupprecht H.J., et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J 145 (2003) 737-741
26. Fukahara K., Minami K., Reiss N., et al. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg 125 (2003) 213-214
27. Dasika U.K., Kanter K.R., and Vincent R. Nickel allergy to the percutaneous patent foramen ovale occluder and subsequent systemic nickel allergy. J Thorac Cardiovasc Surg 126 (2003) 2112
28. Singh H.R., Turner D.R., and Forbes T.J. Nickel allergy and the Amplatzer Septal Occluder. J Invasive Cardiol 16 (2004) 681-682
29. Lai D.W., Saver J.L., Araujo J.A., et al. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter Cardiovasc Interv 66 (2005) 424-426
30. Meier B., and Lock J.E. Contemporary management of patent foramen ovale. Circulation 107 (2003) 5-9
31. Meissner I., Khandheria B.K., Heit J.A., et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47 (2006) 440-445
32. Woods T.D., and Patel A. A critical review of patent foramen ovale detection using saline contrast echocardiography: when bubbles lie. J Am Soc Echocardiogr 19 (2006) 215-222
33. Rodriquez C.J., and Homma S. Patent foramen ovale and stroke. Curr Treat Options Cardiovasc Med 5 (2003) 233-240
34. Beda R.D., and Gill Jr. E.A. Patent foramen ovale: does it play a role in the pathophysiology of migraine headache?. Cardiol Clin 23 (2005) 91-96
35. Schwerzmann M., Seiler C., Lipp E., et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 134 (2001) 21-24
36. Burchell H.B., Helmholtz Jr. H.F., and Wood E.H. Reflex orthostatic dyspnea associated with pulmonary hypertension. Am J Physiol 159 (1949) 563-564
37. Lethen H., Flachskampf F.A., Schneider R., et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 80 (1997) 1066-1069
38. Webster M.W., Chancellor A.M., Smith H.J., et al. Patent foramen ovale in young stroke patients. Lancet 2 (1988) 11-12
39. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
40. Ranoux D., Cohen A., Cabanes L., et al. Patent foramen ovale: is stroke due to paradoxical embolism?. Stroke 24 (1993) 31-34
41. Bogousslavsky J., Garazi S., Jeanrenaud X., et al. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 46 (1996) 1301-1305
42. Homma S., Sacco R.L., Di Tullio M.R., et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105 (2002) 2625-2631
43. Wahl A., Meier B., Haxel B., et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 57 (2001) 1330-1332
44. Khairy P., O'Donnell C.P., and Landzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139 (2003) 753-760
45. Messe S.R., Silverman I.E., Kizer J.R., et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 62 (2004) 1042-1050
46. Windecker S., Wahl A., Nedeltchev K., et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44 (2004) 750-758
47. Schuchlenz H.W., Weihs W., Berghold A., et al. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 101 (2005) 77-82
48. Reisman M., Christofferson R.D., Jesurum J., et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45 (2005) 493-495
49. Azarbal B., Tobis J., Suh W., et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45 (2005) 489-492
50. Bruch L., Parsi A., Grad M.O., et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 105 (2002) 2845-2848
51. Braun M., Gliech V., Boscheri A., et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25 (2004) 424-430